Cingulate Inc. Form 8-K Summary
Business Context and Reporting Period
Cingulate Inc. (CING), a Delaware corporation, filed this Current Report on Form 8-K on June 18, 2024, regarding an event dated June 17, 2024. The Company is listed on The Nasdaq Capital Market and is classified as an emerging growth company.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance regarding stock listing status.
Material Changes
On June 17, 2024, the Company received a letter from the Nasdaq Listing Qualifications Staff notifying it of non-compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The Company failed to maintain this price for the last 30 consecutive business days. Due to the Company's existing status as a discretionary panel monitor through May 21, 2025, Nasdaq did not grant additional time to regain compliance and determined to delist the securities unless a hearing is requested.
Outlook, Management Commentary, and Risks
- Management Action: The Company intends to timely request a hearing before the Nasdaq Hearings Panel. This request will stay any suspension or delisting action pending the hearing.
- Compliance Strategy: The Company plans to take definitive steps to evidence compliance, including potentially effecting a reverse stock split.
- Risks and Contingencies: There is no assurance that the Panel will grant the request for continued listing, that the Company will achieve compliance within any granted extension, or that it will maintain other Nasdaq listing requirements.
Investor Verification Checklist
- Verify the current trading price of CING common stock to assess the severity of the bid price deficiency.
- Monitor for a formal filing confirming the request for a hearing before the Nasdaq Hearings Panel.
- Review future announcements regarding the potential implementation of a reverse stock split.
- Check the status of the discretionary panel monitor period ending May 21, 2025.